Renovorx ceo shaun bagai to present at h.c. wainwright's 27th annual global investment conference in new york city, september 8-10, 2025

Mountain view, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a life sciences company developing innovative targeted oncology therapies and commercializing renovocath®, a patented, fda-cleared drug-delivery device, today announced that shaun bagai, chief executive officer, will present at the h.c. wainwright 27th annual global investment conference. the conference will be held at the lotte new york palace hotel in new york city, september 8-10, 2025. mr. b.
RNXT Ratings Summary
RNXT Quant Ranking